BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 8816498)

  • 1. Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathway.
    Schulte TW; Blagosklonny MV; Romanova L; Mushinski JF; Monia BP; Johnston JF; Nguyen P; Trepel J; Neckers LM
    Mol Cell Biol; 1996 Oct; 16(10):5839-45. PubMed ID: 8816498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the ras/raf-1/MEK/MAPK pathway.
    Geppert TD; Whitehurst CE; Thompson P; Beutler B
    Mol Med; 1994 Nov; 1(1):93-103. PubMed ID: 8790605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hsp90-binding antibiotic geldanamycin decreases Raf levels and epidermal growth factor signaling without disrupting formation of signaling complexes or reducing the specific enzymatic activity of Raf kinase.
    Stancato LF; Silverstein AM; Owens-Grillo JK; Chow YH; Jove R; Pratt WB
    J Biol Chem; 1997 Feb; 272(7):4013-20. PubMed ID: 9020108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes.
    Schönwasser DC; Marais RM; Marshall CJ; Parker PJ
    Mol Cell Biol; 1998 Feb; 18(2):790-8. PubMed ID: 9447975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation.
    Schnaider T; Somogyi J; Csermely P; Szamel M
    Cell Stress Chaperones; 2000 Jan; 5(1):52-61. PubMed ID: 10701840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dominant role for the Raf-MEK pathway in forskolin, 12-O-tetradecanoyl-phorbol acetate, and platelet-derived growth factor-induced CREB (cAMP-responsive element-binding protein) activation, uncoupled from serine 133 phosphorylation in NIH 3T3 cells.
    Seternes OM; Johansen B; Moens U
    Mol Endocrinol; 1999 Jul; 13(7):1071-83. PubMed ID: 10406459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement for a hsp90 chaperone-dependent MEK1/2-ERK pathway for B cell antigen receptor-induced cyclin D2 expression in mature B lymphocytes.
    Piatelli MJ; Doughty C; Chiles TC
    J Biol Chem; 2002 Apr; 277(14):12144-50. PubMed ID: 11823472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geldanamycin-induced destabilization of Raf-1 involves the proteasome.
    Schulte TW; An WG; Neckers LM
    Biochem Biophys Res Commun; 1997 Oct; 239(3):655-9. PubMed ID: 9367823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf.
    Ueda Y; Hirai Si; Osada Si; Suzuki A; Mizuno K; Ohno S
    J Biol Chem; 1996 Sep; 271(38):23512-9. PubMed ID: 8798560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forskolin inhibits protein kinase C-induced mitogen activated protein kinase activity in MC3T3-E1 osteoblasts.
    Siddhanti SR; Hartle JE; Quarles LD
    Endocrinology; 1995 Nov; 136(11):4834-41. PubMed ID: 7588214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the Raf-1-Hsp90 molecular complex results in destabilization of Raf-1 and loss of Raf-1-Ras association.
    Schulte TW; Blagosklonny MV; Ingui C; Neckers L
    J Biol Chem; 1995 Oct; 270(41):24585-8. PubMed ID: 7592678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ras-dependent and -independent pathways target the mitogen-activated protein kinase network in macrophages.
    Büscher D; Hipskind RA; Krautwald S; Reimann T; Baccarini M
    Mol Cell Biol; 1995 Jan; 15(1):466-75. PubMed ID: 7799956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferons block protein kinase C-dependent but not-independent activation of Raf-1 and mitogen-activated protein kinases and mitogenesis in NIH 3T3 cells.
    Xu J; Rockow S; Kim S; Xiong W; Li W
    Mol Cell Biol; 1994 Dec; 14(12):8018-27. PubMed ID: 7526152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin.
    Schulte TW; Neckers LM
    Cancer Chemother Pharmacol; 1998; 42(4):273-9. PubMed ID: 9744771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p50(cdc37) acting in concert with Hsp90 is required for Raf-1 function.
    Grammatikakis N; Lin JH; Grammatikakis A; Tsichlis PN; Cochran BH
    Mol Cell Biol; 1999 Mar; 19(3):1661-72. PubMed ID: 10022854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligation of the T cell receptor complex results in activation of the Ras/Raf-1/MEK/MAPK cascade in human T lymphocytes.
    Franklin RA; Tordai A; Patel H; Gardner AM; Johnson GL; Gelfand EW
    J Clin Invest; 1994 May; 93(5):2134-40. PubMed ID: 8182145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: reconstitution of the signalling pathway in vitro.
    Marquardt B; Frith D; Stabel S
    Oncogene; 1994 Nov; 9(11):3213-8. PubMed ID: 7936644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum, and 12-O-tetradecanoylphorbol-13-acetate requires Raf and is necessary for transformation.
    Troppmair J; Bruder JT; Munoz H; Lloyd PA; Kyriakis J; Banerjee P; Avruch J; Rapp UR
    J Biol Chem; 1994 Mar; 269(9):7030-5. PubMed ID: 8120067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP.
    Yeung K; Seitz T; Li S; Janosch P; McFerran B; Kaiser C; Fee F; Katsanakis KD; Rose DW; Mischak H; Sedivy JM; Kolch W
    Nature; 1999 Sep; 401(6749):173-7. PubMed ID: 10490027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The T-cell antigen receptor utilizes Lck, Raf-1, and MEK-1 for activating mitogen-activated protein kinase. Evidence for the existence of a second protein kinase C-dependent pathway in an Lck-negative Jurkat cell mutant.
    Gupta S; Weiss A; Kumar G; Wang S; Nel A
    J Biol Chem; 1994 Jun; 269(25):17349-57. PubMed ID: 7516337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.